Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse

Overview of attention for article published in SpringerPlus, October 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

facebook: 1 Facebook page
googleplus: 2 Google+ users

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 26 Mendeley

Summary News Policy documents Facebook Google+ Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Botulinum Toxin A for Chronic Migraines: Clinical Effectiveness

Cited by Canadian Agency for Drugs and Technologies in Health on 03 Jan 2018

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.